SARS-CoV-2 structural features may explain limited neutralizing-antibody responses

被引:43
|
作者
Bachmann, Martin F. [1 ,2 ,3 ]
Mohsen, Mona O. [2 ,3 ]
Zha, Lisha [1 ]
Vogel, Monique [1 ]
Speiser, Daniel E. [4 ,5 ]
机构
[1] Anhui Agr Univ, Int Immunol Ctr, Hefei, Peoples R China
[2] Univ Hosp Bern, Dept Rheumatol Immunol & Allergol, Bern, Switzerland
[3] Univ Bern, Dept BioMed Res, Bern, Switzerland
[4] Univ Hosp, Lausanne, Switzerland
[5] Univ Lausanne, Lausanne, Switzerland
基金
瑞士国家科学基金会;
关键词
CORONAVIRUS; IMMUNITY; CELL; ANTIGEN; IMMUNOGENICITY; INFECTION;
D O I
10.1038/s41541-020-00264-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Neutralizing antibody responses of SARS-CoV-2-infected patients may be low and of short duration. We propose here that coronaviruses employ a structural strategy to avoid strong and enduring antibody responses. Other viruses induce optimal and long-lived neutralizing antibody responses, thanks to 20 or more repetitive, rigid antigenic epitopes, spaced by 5-10nm, present on the viral surface. Such arrays of repetitive and highly organized structures are recognized by the immune system as pathogen-associated structural patterns (PASPs), which are characteristic for pathogen surfaces. In contrast, coronaviruses are large particles with long spikes (S protein) embedded in a fluid membrane. Therefore, the neutralizing epitopes (which are on the S protein) are loosely "floating" and widely spaced by an average of about 25nm. Consequently, recruitment of complement is poor and stimulation of B cells remains suboptimal, offering an explanation for the inefficient and short-lived neutralizing antibody responses.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] IgA dominates the early neutralizing antibody response to SARS-CoV-2
    Sterlin, Delphine
    Mathian, Alexis
    Miyara, Makoto
    Mohr, Audrey
    Anna, Francois
    Claer, Laetitia
    Quentric, Paul
    Fadlallah, Jehane
    Devilliers, Herve
    Ghillani, Pascale
    Gunn, Cary
    Hockett, Rick
    Mudumba, Sasi
    Guihot, Amelie
    Luyt, Charles-Edouard
    Mayaux, Julien
    Beurton, Alexandra
    Fourati, Salma
    Bruel, Timothee
    Schwartz, Olivier
    Lacorte, Jean-Marc
    Yssel, Hans
    Parizot, Christophe
    Dorgham, Karim
    Charneau, Pierre
    Amoura, Zahir
    Gorochov, Guy
    SCIENCE TRANSLATIONAL MEDICINE, 2021, 13 (577)
  • [42] Recent Developments in SARS-CoV-2 Neutralizing Antibody Detection Methods
    Jo-Lewis Banga Ndzouboukou
    Yan-di Zhang
    Xiong-lin Fan
    Current Medical Science, 2021, 41 : 1052 - 1064
  • [43] Association of anosmia and neutralizing antibody production in adolescents with SARS-CoV-2
    Gitman, Lyuba
    Newman, Daniel
    Burak, Bahar
    Reilly, Brian K.
    Mudd, Pamela
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2023, 164
  • [44] Persistence of the neutralizing antibody response after SARS-CoV-2 infection
    Shim, Sang-Mu
    Kim, Jun-Won
    Jung, Sunhee
    Jung, Yujung
    Woo, Hye-Min
    Yang, Jeong-Sun
    Kim, Kyung-Chang
    Lee, Joo-Yeon
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (04) : 614.e1 - 614.e4
  • [45] Development of an Effective Neutralizing Antibody Assay for SARS-CoV-2 Diagnosis
    Liu, Zhigang
    Liang, Jiahui
    Hu, Hangzhan
    Wu, Mengli
    Ma, Jingjing
    Ma, Ziwei
    Ji, Jianing
    Chen, Hengyi
    Li, Xiaoquan
    Wang, Zhizeng
    Luo, Yang
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2023, 18 : 3125 - 3139
  • [46] A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge
    He, Xiangchuan
    Ding, Longfei
    Cao, Kangli
    Peng, Haoran
    Gu, Chenjian
    Li, Yutang
    Li, Duoduo
    Dong, Lanlan
    Hong, Xiujing
    Wang, Xiangwei
    Fu, Meilan
    Qiu, Chenli
    Zhu, Cuisong
    Zhang, Ziling
    Song, Shu
    Wang, Chenguang
    Jiang, Zhengfan
    Xie, Youhua
    Qi, Zhongtian
    Zhao, Chen
    Zhao, Ping
    Zhang, Xiaoyan
    Xu, Jianqing
    EMERGING MICROBES & INFECTIONS, 2021, 10 (01) : 1555 - 1573
  • [47] VIRUSES Neutralizing SARS-CoV-2
    Poeschla, Eric
    ELIFE, 2020, 9 : 1 - 4
  • [48] Neutralizing antibody and T cell responses to SARS-CoV-2 vaccination in hematopoietic cell transplant recipients
    Gavriilaki, Eleni
    Papadopoulou, Anastasia
    Touloumenidou, Tasoula
    Stavridou, Fani
    Koravou, Evaggelia-Evdoxia
    Giannaki, Maria
    Papalexandri, Apostolia
    Karavalakis, Georgios
    Batsis, Ioannis
    Kourelis, Andreas
    Chatzopoulou, Fani
    Chatzidimitriou, Dimitrios
    Sotiropoulos, Damianos
    Yannaki, Evangelia
    Sakellari, Ioanna
    Anagnostopoulos, Achilles
    BONE MARROW TRANSPLANTATION, 2022, 57 (07) : 1183 - 1186
  • [49] Assessment of neutralizing antibody responses after natural SARS-CoV-2 infection and vaccination in congolese individuals
    Armel Landry Batchi-Bouyou
    Jean Claude Djontu
    Jeannhey Christevy Vouvoungui
    Claujens Chastel Mfoutou Mapanguy
    Line Lobaloba Ingoba
    Jiré Séphora Mougany
    Kamal Rauchelvy Boumpoutou
    Steve Diafouka-kietela
    Raoul Ampa
    Francine Ntoumi
    BMC Infectious Diseases, 22
  • [50] Neutralizing antibody-dependent and -independent immune responses against SARS-CoV-2 in cynomolgus macaques
    Ishigaki, Hirohito
    Nakayama, Misako
    Kitagawa, Yoshinori
    Nguyen, Cong Thanh
    Hayashi, Kaori
    Shiohara, Masanori
    Gotoh, Bin
    Itoh, Yasushi
    VIROLOGY, 2021, 554 : 97 - 105